We develop innovative solutions based on the analysis of exhaled biomarkers as useful tools for the diagnosis, prognosis, and monitoring of various respiratory diseases, among which asthma stands out. We currently have the evernoa BASE device, which allows to measure airway inflammation by detecting Nitric Oxide through a simple and non-invasive test.
Looking for a particular EVERSENS SL employee's phone or email?
The EVERSENS SL annual revenue was $933000 in 2026.
Jorge Pascual Retuerta is the Chief Commercial Officer (CCO) of EVERSENS SL.
6 people are employed at EVERSENS SL.
EVERSENS SL is based in Noain, Navarre.
The NAICS codes for EVERSENS SL are [5417, 54171, 54, 541, 541713].
The SIC codes for EVERSENS SL are [87, 873].